BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35659274)

  • 1. Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism.
    Chen L; Song Y; Hou T; Li X; Cheng L; Li Y; Xing Y
    J Exp Clin Cancer Res; 2022 Jun; 41(1):194. PubMed ID: 35659274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.
    Zhang H; Li M; Zhang J; Shen Y; Gui Q
    Drug Des Devel Ther; 2021; 15():1835-1849. PubMed ID: 33976535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway.
    Tan X; Song X; Fan B; Li M; Zhang A; Pei L
    Anticancer Drugs; 2022 Oct; 33(9):871-882. PubMed ID: 36136987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
    Zhang W; Song C; Ren X
    Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of circular RNA hsa_circ_0000735 boosts prostate cancer sensitivity to docetaxel via sponging miR-7.
    Gao Y; Liu J; Huan J; Che F
    Cancer Cell Int; 2020; 20():334. PubMed ID: 32714093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression.
    Wu C; Miao C; Tang Q; Zhou X; Xi P; Chang P; Hua L; Ni H
    J Cell Mol Med; 2020 Feb; 24(3):2098-2108. PubMed ID: 31876385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer.
    Babasaki T; Sentani K; Sekino Y; Kobayashi G; Thang Pham Q; Katsuya N; Akabane S; Taniyama D; Hayashi T; Shiota M; Oue N; Teishima J; Matsubara A; Yasui W
    Cancer Med; 2021 Aug; 10(16):5574-5588. PubMed ID: 34240817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
    Xue D; Lu H; Xu HY; Zhou CX; He XZ
    J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0006404 and hsa_circ_0000735 Regulated Ovarian Cancer Response to Docetaxel Treatment via Regulating p-GP Expression.
    Chen YY; Tai YC
    Biochem Genet; 2022 Feb; 60(1):395-414. PubMed ID: 34255218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of circDPP4 suppresses cell progression of human prostate cancer and enhances docetaxel cytotoxicity through regulating the miR-564/ZIC2 axis.
    Gu H; Duan Z
    J Gene Med; 2022 Mar; 24(3):e3403. PubMed ID: 34904327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircTHSD4 promotes the malignancy and docetaxel (DTX) resistance in prostate cancer by regulating miR-203/HMGA2 axis.
    Xie J; Lu L; Zhang J; Li Q; Chen W
    Oncol Res; 2024; 32(3):529-544. PubMed ID: 38361751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_0003998 Promotes Chemoresistance via Modulation of miR-326 in Lung Adenocarcinoma Cells.
    Yu W; Peng W; Sha H; Li J
    Oncol Res; 2019 May; 27(5):623-628. PubMed ID: 30764896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic activation of METTL14 promotes docetaxel resistance in prostate cancer by promoting pri-microRNA-129 maturation.
    Wu C; Miao C; Zhou S; Chang PA; He B; Zhou X; Tang Q
    Environ Toxicol; 2024 Jun; 39(6):3734-3745. PubMed ID: 38546343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA.
    Mao S; Zhang W; Yang F; Guo Y; Wang H; Wu Y; Wang R; Maskey N; Zheng Z; Li C; Ma W; Zhang J; Yan Y; Yao X
    J Exp Clin Cancer Res; 2021 Oct; 40(1):336. PubMed ID: 34696782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p.
    Yu YZ; Lv DJ; Wang C; Song XL; Xie T; Wang T; Li ZM; Guo JD; Fu DJ; Li KJ; Wu DL; Chan FL; Feng NH; Chen ZS; Zhao SC
    Mol Cancer; 2022 Jan; 21(1):12. PubMed ID: 34986849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.
    Li Y; Zhang B; Xiang L; Xia S; Kucuk O; Deng X; Boise LH; Dong JT
    Theranostics; 2020; 10(17):7656-7670. PubMed ID: 32685011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircRNA circ_0006156 inhibits the metastasis of prostate cancer by blocking the ubiquitination of S100A9.
    Zhang Y; Liu F; Feng Y; Xu X; Wang Y; Zhu S; Dong J; Zhao S; Xu B; Feng N
    Cancer Gene Ther; 2022 Nov; 29(11):1731-1741. PubMed ID: 35760899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.
    Sekino Y; Han X; Kawaguchi T; Babasaki T; Goto K; Inoue S; Hayashi T; Teishima J; Shiota M; Yasui W; Matsubara A
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOTCH3 promotes docetaxel resistance of prostate cancer cells through regulating TUBB3 and MAPK signaling pathway.
    Sun X; Zhang Y; Xin S; Jin L; Cao Q; Wang H; Wang K; Liu X; Tang C; Li W; Li Z; Wen X; Yang G; Guo C; Liu Z; Ye L
    Cancer Sci; 2024 Feb; 115(2):412-426. PubMed ID: 38115797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1.
    Hong X; Liu N; Liang Y; He Q; Yang X; Lei Y; Zhang P; Zhao Y; He S; Wang Y; Li J; Li Q; Ma J; Li Y
    Mol Cancer; 2020 Feb; 19(1):33. PubMed ID: 32061262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.